JP2012097034A5 - - Google Patents

Download PDF

Info

Publication number
JP2012097034A5
JP2012097034A5 JP2010246112A JP2010246112A JP2012097034A5 JP 2012097034 A5 JP2012097034 A5 JP 2012097034A5 JP 2010246112 A JP2010246112 A JP 2010246112A JP 2010246112 A JP2010246112 A JP 2010246112A JP 2012097034 A5 JP2012097034 A5 JP 2012097034A5
Authority
JP
Japan
Prior art keywords
composition
hipokisanchi
autoinducer
creatine
taurine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010246112A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012097034A (ja
JP5756614B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010246112A priority Critical patent/JP5756614B2/ja
Priority claimed from JP2010246112A external-priority patent/JP5756614B2/ja
Publication of JP2012097034A publication Critical patent/JP2012097034A/ja
Publication of JP2012097034A5 publication Critical patent/JP2012097034A5/ja
Application granted granted Critical
Publication of JP5756614B2 publication Critical patent/JP5756614B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010246112A 2010-11-02 2010-11-02 オートインデューサー−2阻害剤、並びに齲蝕病の予防及び/又は治療剤 Active JP5756614B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010246112A JP5756614B2 (ja) 2010-11-02 2010-11-02 オートインデューサー−2阻害剤、並びに齲蝕病の予防及び/又は治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010246112A JP5756614B2 (ja) 2010-11-02 2010-11-02 オートインデューサー−2阻害剤、並びに齲蝕病の予防及び/又は治療剤

Publications (3)

Publication Number Publication Date
JP2012097034A JP2012097034A (ja) 2012-05-24
JP2012097034A5 true JP2012097034A5 (hr) 2013-10-31
JP5756614B2 JP5756614B2 (ja) 2015-07-29

Family

ID=46389377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010246112A Active JP5756614B2 (ja) 2010-11-02 2010-11-02 オートインデューサー−2阻害剤、並びに齲蝕病の予防及び/又は治療剤

Country Status (1)

Country Link
JP (1) JP5756614B2 (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2593618T3 (es) * 2012-12-18 2016-12-12 Sunstar Suisse Sa Composición oral tópica para aliviar los síntomas de la boca seca y para el tratamiento de úlceras bucales
WO2017127025A1 (en) * 2016-01-19 2017-07-27 Namz Pte. Ltd. A cosmetic composition and the use thereof for regulating skin quality
CN108042384B (zh) * 2018-01-08 2020-07-10 弘美制药(中国)有限公司 一种具有口腔清洁和治疗功效的组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69813908T2 (de) * 1998-07-28 2004-02-05 Synthes Ag Chur, Chur Verwendung von kreatinsubstanzen zur behandlung von knochen- und knorpelzellen und geweben
DE19841385A1 (de) * 1998-09-10 2000-03-16 Sueddeutsche Kalkstickstoff Verwendung von Kreatin und/oder Kreatin-derivaten als Feuchthaltemittel in kosmetischen Zubereitungen
JP2010159219A (ja) * 2009-01-07 2010-07-22 Kao Corp Ai−2阻害剤

Similar Documents

Publication Publication Date Title
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
JP2015523407A5 (hr)
AR080491A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
BR112013032122A2 (pt) liberação modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)fenil] benzamida solubilizada usando ácidos orgânicos
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
EA200901423A1 (ru) Бензимидазолы и содержащие их фармацевтические композиции
BRPI0814666A2 (pt) composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida
JP2007238598A5 (hr)
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
BRPI0807285A2 (pt) "composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto"
SG10201506708UA (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
WO2011056240A3 (en) Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
JP2009537554A5 (hr)
ATE505203T1 (de) Pharmazeutische kombination aus aliskiren und valsartan
NO20044547L (no) Nye farmasoytiske sammensetninger inneholdende flibanserin
JP2012508256A5 (hr)
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
JP2012097034A5 (hr)
JP2012097036A5 (hr)
JP2013032308A5 (hr)
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
MX338975B (es) Composicion farmaceutica que contiene sales de citrato y bicarbonato, y su uso para el tratamiento de la cistinuria.
CY1111361T1 (el) Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια
RU2011143735A (ru) Средство для отбеливания кожи и косметический способ отбеливания кожи